vs
Side-by-side financial comparison of Elanco Animal Health Inc (ELAN) and Take-Two Interactive (TTWO). Click either name above to swap in a different company.
Take-Two Interactive is the larger business by last-quarter revenue ($1.7B vs $1.1B, roughly 1.5× Elanco Animal Health Inc). Take-Two Interactive runs the higher net margin — -5.5% vs -24.1%, a 18.7% gap on every dollar of revenue. On growth, Take-Two Interactive posted the faster year-over-year revenue change (24.9% vs 12.2%). Take-Two Interactive produced more free cash flow last quarter ($236.2M vs $46.0M). Over the past eight quarters, Take-Two Interactive's revenue compounded faster (10.2% CAGR vs -2.6%).
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.
Take-Two Interactive Software, Inc. is an American video game holding company based in New York City founded by Ryan Brant in September 1993.
ELAN vs TTWO — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.7B |
| Net Profit | $-276.0M | $-92.9M |
| Gross Margin | 51.5% | 55.7% |
| Operating Margin | -22.6% | -2.3% |
| Net Margin | -24.1% | -5.5% |
| Revenue YoY | 12.2% | 24.9% |
| Net Profit YoY | -3350.0% | 25.8% |
| EPS (diluted) | $-0.55 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.7B | ||
| Q3 25 | $1.1B | $1.8B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.2B | $1.6B | ||
| Q4 24 | $1.0B | $1.4B | ||
| Q3 24 | $1.0B | $1.4B | ||
| Q2 24 | $1.2B | $1.3B | ||
| Q1 24 | $1.2B | $1.4B |
| Q4 25 | $-276.0M | $-92.9M | ||
| Q3 25 | $-34.0M | $-133.9M | ||
| Q2 25 | $11.0M | $-11.9M | ||
| Q1 25 | $67.0M | $-3.7B | ||
| Q4 24 | $-8.0M | $-125.2M | ||
| Q3 24 | $364.0M | $-365.5M | ||
| Q2 24 | $-50.0M | $-262.0M | ||
| Q1 24 | $32.0M | $-2.9B |
| Q4 25 | 51.5% | 55.7% | ||
| Q3 25 | 53.4% | 55.3% | ||
| Q2 25 | 57.5% | 62.8% | ||
| Q1 25 | 57.3% | 50.8% | ||
| Q4 24 | 50.9% | 55.9% | ||
| Q3 24 | 52.2% | 53.8% | ||
| Q2 24 | 58.2% | 57.6% | ||
| Q1 24 | 57.3% | 33.5% |
| Q4 25 | -22.6% | -2.3% | ||
| Q3 25 | -4.4% | -5.5% | ||
| Q2 25 | 2.0% | 1.4% | ||
| Q1 25 | 5.0% | -238.7% | ||
| Q4 24 | -5.0% | -9.7% | ||
| Q3 24 | 54.3% | -22.0% | ||
| Q2 24 | -2.7% | -13.8% | ||
| Q1 24 | 1.0% | -193.9% |
| Q4 25 | -24.1% | -5.5% | ||
| Q3 25 | -3.0% | -7.5% | ||
| Q2 25 | 0.9% | -0.8% | ||
| Q1 25 | 5.6% | -235.5% | ||
| Q4 24 | -0.8% | -9.2% | ||
| Q3 24 | 35.3% | -27.0% | ||
| Q2 24 | -4.2% | -19.6% | ||
| Q1 24 | 2.7% | -207.4% |
| Q4 25 | $-0.55 | $-0.50 | ||
| Q3 25 | $-0.07 | $-0.73 | ||
| Q2 25 | $0.02 | $-0.07 | ||
| Q1 25 | $0.13 | $-21.27 | ||
| Q4 24 | $-0.01 | $-0.71 | ||
| Q3 24 | $0.73 | $-2.08 | ||
| Q2 24 | $-0.10 | $-1.52 | ||
| Q1 24 | $0.06 | $-17.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $545.0M | $2.4B |
| Total DebtLower is stronger | $3.9B | — |
| Stockholders' EquityBook value | $6.5B | $3.5B |
| Total Assets | $13.4B | $10.0B |
| Debt / EquityLower = less leverage | 0.60× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $545.0M | $2.4B | ||
| Q3 25 | $505.0M | $2.1B | ||
| Q2 25 | $539.0M | $2.0B | ||
| Q1 25 | $487.0M | $1.5B | ||
| Q4 24 | $468.0M | $1.2B | ||
| Q3 24 | $490.0M | $879.6M | ||
| Q2 24 | $416.0M | $1.1B | ||
| Q1 24 | $345.0M | $776.0M |
| Q4 25 | $3.9B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.4B | — | ||
| Q4 24 | $4.3B | — | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $5.8B | — |
| Q4 25 | $6.5B | $3.5B | ||
| Q3 25 | $6.7B | $3.4B | ||
| Q2 25 | $6.8B | $3.5B | ||
| Q1 25 | $6.4B | $2.1B | ||
| Q4 24 | $6.1B | $5.7B | ||
| Q3 24 | $6.5B | $5.8B | ||
| Q2 24 | $5.9B | $6.0B | ||
| Q1 24 | $6.1B | $5.7B |
| Q4 25 | $13.4B | $10.0B | ||
| Q3 25 | $13.6B | $10.1B | ||
| Q2 25 | $13.7B | $9.7B | ||
| Q1 25 | $12.9B | $9.2B | ||
| Q4 24 | $12.6B | $12.7B | ||
| Q3 24 | $13.3B | $13.1B | ||
| Q2 24 | $13.8B | $12.9B | ||
| Q1 24 | $14.0B | $12.2B |
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.70× | — | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.96× | — | ||
| Q1 24 | 0.95× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.0M | $305.2M |
| Free Cash FlowOCF − Capex | $46.0M | $236.2M |
| FCF MarginFCF / Revenue | 4.0% | 13.9% |
| Capex IntensityCapex / Revenue | 5.4% | 4.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $284.0M | $487.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.0M | $305.2M | ||
| Q3 25 | $219.0M | $128.4M | ||
| Q2 25 | $237.0M | $-44.7M | ||
| Q1 25 | $-4.0M | $279.0M | ||
| Q4 24 | $177.0M | $-4.8M | ||
| Q3 24 | $162.0M | $-128.4M | ||
| Q2 24 | $200.0M | $-191.0M | ||
| Q1 24 | $2.0M | $-8.9M |
| Q4 25 | $46.0M | $236.2M | ||
| Q3 25 | $127.0M | $96.5M | ||
| Q2 25 | $180.0M | $-69.8M | ||
| Q1 25 | $-69.0M | $224.9M | ||
| Q4 24 | $130.0M | $-48.2M | ||
| Q3 24 | $120.0M | $-165.2M | ||
| Q2 24 | $166.0M | $-226.1M | ||
| Q1 24 | $-22.0M | $-55.1M |
| Q4 25 | 4.0% | 13.9% | ||
| Q3 25 | 11.2% | 5.4% | ||
| Q2 25 | 14.5% | -4.6% | ||
| Q1 25 | -5.8% | 14.2% | ||
| Q4 24 | 12.7% | -3.5% | ||
| Q3 24 | 11.7% | -12.2% | ||
| Q2 24 | 14.0% | -16.9% | ||
| Q1 24 | -1.8% | -3.9% |
| Q4 25 | 5.4% | 4.1% | ||
| Q3 25 | 8.1% | 1.8% | ||
| Q2 25 | 4.6% | 1.7% | ||
| Q1 25 | 5.4% | 3.4% | ||
| Q4 24 | 4.6% | 3.2% | ||
| Q3 24 | 4.1% | 2.7% | ||
| Q2 24 | 2.9% | 2.6% | ||
| Q1 24 | 2.0% | 3.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 21.55× | — | ||
| Q1 25 | -0.06× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.06× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
TTWO
Segment breakdown not available.
